Reliant Pharmaceuticals
Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 for $1.65B.[1] Co-founded by Joseph J. Krivulka.
It was known for six major products, including [[Lovaza|Omacor/Lovaza](Omega-3)], Axid(H2 blocker), Dynacirc CR (calcium channel blocker), Antara (fenofibrate), InnoPran XL (beta blocker), and Rythmol SR (Class IC anti-arrhythmic).
Reliant Pharmaceuticals, Inc. was a pharmaceutical company that specialized in the development, commercialization and marketing of prescription therapeutic products. Reliant marketed six cardiovascular products in the United States and focused on promoting its products to targeted primary care and specialty physicians, as well as selected hospitals and academic centers in the United States. Reliants' sales force consisted of approximately 650 sales and marketing professionals nationwide.
References
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
